Pharmacogenetic Markers for Metabolic Impairments in Treatment with Valproic Acid

被引：0
|
作者：
Drokov A.P. [1 ]
Lipatova L.V. [1 ]
Shnayder N.A. [1 ]
Nasyrova R.F. [1 ]
机构：
[1] Bekhterev National Medical Research Center of Psychiatry and Neurology, Russian Ministry of Health, St. Petersburg
来源：
Neuroscience and Behavioral Physiology | 2020年 / 50卷 / 1期
关键词：
adipokines; insulin resistance; metabolic impairments; obesity; undesirable side effects; valproic acid;
D O I：
10.1007/s11055-019-00861-6
中图分类号：
学科分类号：
摘要：
This review presents studies of the association between the use of sodium valproate formulations and increases in body weight in patients with epilepsy, as well as other valproate-induced side effects, including insulin resistance. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码：13 / 19
页数：6
相关论文
共 50 条
  • [1] Metabolic and endocrine effects of valproic acid chronic treatment
    Belcastro, Vincenzo
    D'Egidio, Claudia
    Striano, Pasquale
    Verrotti, Alberto
    EPILEPSY RESEARCH, 2013, 107 (1-2) : 1 - 8
  • [2] Metabolic Alterations During Valproic Acid Treatment: A Prospective Study
    Abaci, Ayhan
    Saygi, Murat
    Yis, Uluc
    Demir, Korcan
    Dirik, Eray
    Bober, Ece
    PEDIATRIC NEUROLOGY, 2009, 41 (06) : 435 - 439
  • [3] METABOLIC INTERACTION OF VALPROIC ACID
    BORCHERT, HH
    SCHUSTER, S
    PFEIFER, S
    PHARMAZIE, 1980, 35 (5-6): : 313 - 314
  • [4] Impairments of social interaction in a valproic acid model in mice
    Ukezono, Masatoshi
    Kasahara, Yoshiyuki
    Yoshida, Chihiro
    Murakami, Yuki
    Okada, Takashi
    Takano, Yuji
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2024, 18
  • [5] METABOLIC AND NUTRITIONAL IMPLICATIONS OF VALPROIC ACID
    NURGE, ME
    ANDERSON, CR
    BATES, E
    NUTRITION RESEARCH, 1991, 11 (08) : 949 - 960
  • [6] PHARMACOGENETIC MARKERS FOR TOXICITY PREDICTION IN ONCOLOGICAL TREATMENT
    Lopez Fernandez, L. A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 24 - 24
  • [7] THE CONTRIBUTION OF GENOMIC AND PHARMACOGENETIC MARKERS FOR TREATMENT DECISION
    Johnston, P. G.
    ANNALS OF ONCOLOGY, 2008, 19 : 32 - 32
  • [8] Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid
    Nisha, Yadav
    Bobby, Zachariah
    Wadwekar, Vaibhav
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 60 : 57 - 60
  • [9] Reduced Adult Hippocampal Neurogenesis and Cognitive Impairments following Prenatal Treatment of the Antiepileptic Drug Valproic Acid
    Juliandi, Berry
    Tanemura, Kentaro
    Igarashi, Katsuhide
    Tominaga, Takashi
    Furukawa, Yusuke
    Otsuka, Maky
    Moriyama, Noriko
    Ikegami, Daigo
    Abematsu, Masahiko
    Sanosaka, Tsukasa
    Tsujimura, Keita
    Narita, Minoru
    Kanno, Jun
    Nakashima, Kinichi
    STEM CELL REPORTS, 2015, 5 (06): : 996 - 1009
  • [10] Valproic Acid in the Treatment of Migraines
    Brown, Brandy L.
    Craycraft, Lauren K.
    Justice, Stephanie Baker
    ADVANCED EMERGENCY NURSING JOURNAL, 2020, 42 (04) : 243 - 253
12345